Homeless drug users' awareness and risk perception of peer "take home naloxone" use--a qualitative study - PubMed (original) (raw)
Homeless drug users' awareness and risk perception of peer "take home naloxone" use--a qualitative study
Nat Wright et al. Subst Abuse Treat Prev Policy. 2006.
Abstract
Background: Peer use of take home naloxone has the potential to reduce drug related deaths. There appears to be a paucity of research amongst homeless drug users on the topic. This study explores the acceptability and potential risk of peer use of naloxone amongst homeless drug users. From the findings the most feasible model for future treatment provision is suggested.
Methods: In depth face-to-face interviews conducted in one primary care centre and two voluntary organisation centres providing services to homeless drug users in a large UK cosmopolitan city. Interviews recorded, transcribed and analysed thematically by framework techniques.
Results: Homeless people recognise signs of a heroin overdose and many are prepared to take responsibility to give naloxone, providing prior training and support is provided. Previous reports of the theoretical potential for abuse and malicious use may have been overplayed.
Conclusion: There is insufficient evidence to recommend providing "over the counter" take home naloxone" to UK homeless injecting drug users. However a programme of peer use of take home naloxone amongst homeless drug users could be feasible providing prior training is provided. Peer education within a health promotion framework will optimise success as current professionally led health promotion initiatives are failing to have a positive impact amongst homeless drug users.
Similar articles
- Is a randomised controlled trial of take home naloxone distributed in emergency settings likely to be feasible and acceptable? Findings from a UK qualitative study exploring perspectives of people who use opioids and emergency services staff.
Sampson FC, Hughes J, Long J, Buykx P, Goodacre SW, Snooks H, Edwards A, Evans B, Jones J, Moore C, Johnston S. Sampson FC, et al. BMC Emerg Med. 2024 Apr 29;24(1):75. doi: 10.1186/s12873-024-00987-y. BMC Emerg Med. 2024. PMID: 38679713 Free PMC article. - Naloxone and the Inner City Youth Experience (NICYE): a community-based participatory research study examining young people's perceptions of the BC take home naloxone program.
Mitchell K, Durante SE, Pellatt K, Richardson CG, Mathias S, Buxton JA. Mitchell K, et al. Harm Reduct J. 2017 Jun 7;14(1):34. doi: 10.1186/s12954-017-0160-3. Harm Reduct J. 2017. PMID: 28592287 Free PMC article. - Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities.
Beletsky L, Ruthazer R, Macalino GE, Rich JD, Tan L, Burris S. Beletsky L, et al. J Urban Health. 2007 Jan;84(1):126-36. doi: 10.1007/s11524-006-9120-z. J Urban Health. 2007. PMID: 17146712 Free PMC article. - Do heroin overdose patients require observation after receiving naloxone?
Willman MW, Liss DB, Schwarz ES, Mullins ME. Willman MW, et al. Clin Toxicol (Phila). 2017 Feb;55(2):81-87. doi: 10.1080/15563650.2016.1253846. Epub 2016 Nov 16. Clin Toxicol (Phila). 2017. PMID: 27849133 Review. - [The message from heroin overdoses].
Pap Á, Hegedűs K. Pap Á, et al. Orv Hetil. 2015 Mar 1;156(9):352-7. doi: 10.1556/OH.2015.30091. Orv Hetil. 2015. PMID: 25702255 Review. Hungarian.
Cited by
- Emotional reactions of trained overdose responders who use opioids following intervention in an overdose event.
Brandt L, Campbell ANC, Jones JD, Martinez S, Neale J, Parkin S, Brown C, Strang J, Comer SD. Brandt L, et al. Subst Abus. 2022;43(1):581-591. doi: 10.1080/08897077.2021.1975870. Epub 2021 Sep 14. Subst Abus. 2022. PMID: 34520679 Free PMC article. Clinical Trial. - Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysis.
Neale J, Kalk NJ, Parkin S, Brown C, Brandt L, Campbell ANC, Castillo F, Jones JD, Strang J, Comer SD. Neale J, et al. J Subst Abuse Treat. 2020 Oct;117:108099. doi: 10.1016/j.jsat.2020.108099. Epub 2020 Aug 5. J Subst Abuse Treat. 2020. PMID: 32811629 Free PMC article. Clinical Trial. - Endogenous opiates and behavior: 2006.
Bodnar RJ. Bodnar RJ. Peptides. 2007 Dec;28(12):2435-513. doi: 10.1016/j.peptides.2007.09.002. Epub 2007 Sep 11. Peptides. 2007. PMID: 17949854 Free PMC article. Review. - Stakeholders' Perceptions of Factors Influencing the Use of Take-Home-Naloxone.
Holland TJ, Penm J, Johnson J, Sarantou M, Chaar BB. Holland TJ, et al. Pharmacy (Basel). 2020 Dec 3;8(4):232. doi: 10.3390/pharmacy8040232. Pharmacy (Basel). 2020. PMID: 33287294 Free PMC article. Review. - A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs.
Sajwani HS, Williams AV. Sajwani HS, et al. Harm Reduct J. 2022 Oct 20;19(1):117. doi: 10.1186/s12954-022-00700-x. Harm Reduct J. 2022. PMID: 36266701 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical